Evidence map›Paper›PMID 30392136›Full record

ArticleEuropean journal of nutrition2019

Metabolomics analysis revealed metabolic changes in patients with diarrhea-predominant irritable bowel syndrome and metabolic responses to a synbiotic yogurt intervention.

Hamid Noorbakhsh, Masoud Yavarmanesh, Seyed Ali Mortazavi, Peyman Adibi, Ali A Moazzami

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nutrition, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Functional and chemical properties ofFood chemistry: X · 2023
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Effects ofFrontiers in nutrition · 2021
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Hamid NoorbakhshDepartment of Food Science and Technology, Collage of Agriculture, Ferdowsi University of Mashhad, Mashhad, Iran.
Masoud YavarmaneshDepartment of Food Science and Technology, Collage of Agriculture, Ferdowsi University of Mashhad, Mashhad, Iran. yavarmanesh@um.ac.ir.
Seyed Ali MortazaviDepartment of Food Science and Technology, Collage of Agriculture, Ferdowsi University of Mashhad, Mashhad, Iran.
Peyman AdibiIntegrative Functional Gastroenterology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Ali A MoazzamiDepartment of Molecular Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Ferdowsi University of Mashhad · IRIsfahan University of Medical Sciences · IRSwedish University of Agricultural Sciences · SE

Funding

Ferdowsi University of Mashhad 37938
6 · The paper itself

Abstract

purposeIrritable bowel syndrome is a gastrointestinal disorder which can influence human metabolism. It has been demonstrated that probiotics are beneficial in controlling IBS. Thus, the main objective of the present study was to determine metabolic changes in response to diarrhea predominant irritable bowel syndrome (IBS-D) and to investigate the metabolic effects of a synbiotic intervention on serum, urine, and stool samples from IBS-D patients and healthy controls using proton nuclear magnetic resonance (

methodsA

resultsAt the baseline, serum acetoacetate, myo-inositol, and sarcosine concentrations were higher and threonine and methionine concentrations were lower in the IBS-D cohort than the control group. Moreover, Indoxyl-sulfate concentration of urine was lower and dimethylamine and taurine were higher in the IBS-D group. After intervention, serum concentration of ketone bodies decreased, choline, phenylalanine, and branched-chain amino acids increased in IBS-D group. Metabolomics analysis indicated a shift in one-carbon metabolism. Thus, the level of serum homocysteine was determined and found to be higher in the IBS-D cohort at baseline, and then decreased after the intervention.

conclusionIBS causes a shift in one-carbon metabolism and these changes can be reversed by a synbiotic intervention. An increase in the number of fecal Lactobacilli and an improvement in the health status of IBS-D patients were also observed in response to intervention.

Indexed as

Gastrointestinal MicrobiomeYogurtAdultDiarrheaFemaleGastrointestinal TractHumansIranIrritable Bowel SyndromeMagnetic Resonance SpectroscopyMaleMetabolomicsSynbioticsDiarrhea-predominant irritable bowel syndromeGut microbiotaHomocysteineMetabolomicsOne-carbon metabolism

Identifiers

PMID30392136
OpenAlexW2899514890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.